drugset
drugset / Trial / NCT00195559

Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

NCT00195559 ↗

Phase 3 Completed 526 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether Levonorgestrel/Ethinyl Estradiol (LNG/EE) is effective in treating the symptoms of severe Premenstrual Dysphoric Disorder.

Timeline

Start
2005-09
Primary completion
—
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule — —
Subject ethinyl estradiol Small molecule — —

Indications

premenstrual dysphoric disorder